Last week, Australia’s deputy chief medical officer told GPs to be more proactive in raising awareness about new COVID-19 antiviral treatments with their at-risk patients.
These drugs – nirmatrelvir–ritonavir (Paxlovid) and molnupiravir (Lagevrio) – are effective in keeping people out of hospital and are meant to be bringing down the death rate, which stands at more than 1000 people a month.
